Kaniskov VLand Iliev IE
Abstract
Multiple sclerosis (MS) is a chronic autoimmune disorder affecting the central nervous system (CNS). Its cause is still unknown but it is connected to certain demyelination of the axons in the brain and spinal cord. Despite the medical advances, in the 21st century, multiple sclerosis remains an incurable disease. In order to stop the MS progression, we should concentrate our efforts on reversing the process of demyelination and on improving the transmission of nerve impulses along CNS. The daily administration of nivaline and atropine in combination with regular electromagnetic physiotherapeutic procedures showed potential to reverse the course of MS manifesting itself with a clinical remission of patients with MS. Our findings suggest that the treatment regimen proposed here possesses the potential to stop the process of demyelination in the CNS and stimulate the process of remyelination in MS patients thus achieving a state of clinical remission.